Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-26-000002

Chief Scientific Officer sold 13,000 shares at $2.69 ($34,953)

  • Chief Scientific Officer acquired 13,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Moreadith Randall Chief Scientific Officer 2026-01-08 Option exercise 10b5-1 +13,000 $0.06 $780 13,000 D
Moreadith Randall Chief Scientific Officer 2026-01-08 Sale 10b5-1 −13,000 $2.69 $34,953 0 D
Derivatives
Moreadith Randall Chief Scientific Officer 2026-01-08 Option exercise · Stock Option (right to buy) 10b5-1 −13,000 339,186 D
Open-market sales · 13,000 sh · avg $2.69 · $34,953
Loading xslF345X05/wk-form4_1767979647.xml…